List view / Grid view
26 April 2018 | By Charles River Laboratories
This webinar highlights cell based assays for Parkinson’s disease that include endpoints such as a-synuclein aggregation and mitophagy readouts.
Scientists have developed a breakthrough CRISPR gene-editing tool, that could allow researchers to quickly and precisely engineer multiple changes to the genetic code...
In this application note, BMG Labtech discuss how the Bioluminescence resonance energy transfer (BRET) is a versatile tool to study interactions and trafficking in proteins.
Using genetic engineering technology, a team of scientists have established an animal model of Huntington's disease...
Predictiveness is one of the key factors for success in the drug discovery workflow. Many compounds fail at late stages due to lack of predictive data or the discovery of unwanted side effects.
Study provides a roadmap for using CRISPR to investigate neurological disorders...
Genome editing could enable new strategies to prevent malaria transmission to humans...
Improvements to gene-editing techniques hold promise for inactivating the defective gene responsible for this as-yet incurable disease...
DETECTR system allows quick, one-step detection and diagnosis of disease, infection...
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of mutations that cause DMD...
SMi Reports: SMi’s 2nd annual Drug Discovery conference, taking place in London on 21 and 22 March 2018, will discuss the role of artificial intelligence in drug discovery.
Researchers have identified an enzyme that appears to drive the conversion of normal colon tissue into cancer...
Researchers have developed a system to model Huntington's in human embryonic stem cells...
Researchers have turned skin cells from mice into stem cells by activating Sox2 and Oct4 using CRISPR technology...
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
